These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9342009)

  • 21. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].
    Ezhov MV; Afanas'eva OI; Benevolenskaia GF; Savchenko AP; Balakhonova TV; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 2000; 72(1):28-32. PubMed ID: 10687202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in normoglycaemic relatives of type 2 diabetic patients.
    Stewart MW; Webster JM; Humphriss D; Berrish T; Walker M; Laker MF
    Atherosclerosis; 1996 Jul; 124(1):119-24. PubMed ID: 8800499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
    Viney NJ; van Capelleveen JC; Geary RS; Xia S; Tami JA; Yu RZ; Marcovina SM; Hughes SG; Graham MJ; Crooke RM; Crooke ST; Witztum JL; Stroes ES; Tsimikas S
    Lancet; 2016 Nov; 388(10057):2239-2253. PubMed ID: 27665230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response.
    Lippi G; Braga V; Adami S; Guidi G
    Clin Chim Acta; 1998 Mar; 271(1):79-87. PubMed ID: 9564559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.
    Gaw A; Docherty G; Brown EA; Ford I
    Atherosclerosis; 1999 Apr; 143(2):445-50. PubMed ID: 10217375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
    Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
    Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration.
    Bigot E; Robert B; Bard JM; Mainard F
    Clin Chim Acta; 1997 Sep; 265(1):99-111. PubMed ID: 9352133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
    J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
    Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
    Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
    Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F
    Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum Lp(a) concentration and the rare apo(a) phenotype in a patient with myocardial infarction.
    Hibino T; Sakuma N; Hashimoto T; Ohte N; Yoneyama A; Satoh T; Fujinami T
    Clin Cardiol; 1996 Sep; 19(9):758-9. PubMed ID: 8874999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
    Shi H; Fang J; Yang X; Shen Z; Zhu X
    Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
    Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients.
    Kandoussi AM; Hugue V; Cachera C; Hazzan M; Dracon M; Tacquet A; Noël C
    Nephron; 1998 Oct; 80(2):183-7. PubMed ID: 9736817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.
    Suzuki T; Futami-Suda S; Igari Y; Watanabe K; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H; Oba K
    Lipids Health Dis; 2013 Mar; 12():31. PubMed ID: 23496967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
    Emanuele E; Peros E; Minoretti P; Falcone C; D'Angelo A; Montagna L; Geroldi D
    BMC Cardiovasc Disord; 2003 Dec; 3():12. PubMed ID: 14670093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
    Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
    JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.